Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial.

ABSTRACT:

SUBMITTER: Absalon J 

PROVIDER: S-EPMC9760110 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature